Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Jul;80(9):1366–1372. doi: 10.1038/sj.bjc.6690530

Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer

F Sato 1, Y Shimada 1, G Watanabe 1, S Uchida 1, T Makino 1, M Imamura 1
PMCID: PMC2363062  PMID: 10424737

Abstract

Lymph node metastasis is a strong independent prognostic factor for oesophageal cancer. The expression of matrix metalloproteinases (MMPs) and reduction of E-cadherin correlate with lymph node metastasis of oesophageal cancer. We previously reported that the expression of vascular endothelial growth factor (VEGF) is associated with lymph node metastasis. This study was designed to determine whether VEGF, MMP-9 and E-cadherin expression is stable or changes in the process of lymph node metastasis of oesophageal cancer. Using immunohistochemistry, we detected VEGF, MMP-9 and E-cadherin expression in paraffin-embedded specimens of oesophageal squamous cell carcinoma. We classified 134 primary tumours and 174 nodal metastases using two different criteria: the absence [Group N(–)] or presence [Group N(+)] of nodal metastasis, and the stage of metastasis – Early Stage (cancer cells < 50% of lymph node) or Late Stage (≥ 50%) – and compared the expression among two groups and among two stages. The expression rates of Group N(–), Group N(+), Early Stage and Late Stage are as follows: VEGF (49%, 74%, 60%, 33%), MMP-9 (76%, 65%, 95%, 69%) and E-cadherin (49%, 24%, 55%, 38%). VEGF expression was down-regulated in Late Stage lymph node metastasis, while MMP-9 expression was elevated in Early Stage metastasis. E-cadherin expression is restored somewhat in Early Stage metastasis, but suppressed again in Late Stage metastasis. These data suggest that the expression of VEGF, MMP-9 and E-cadherin each change in the process of lymph node metastasis in oesophageal cancer, and that the patterns of change are different. © 1999 Cancer Research Campaign

Keywords: oesophageal cancer; lymph node metastasis; MMP-9; VEGF, E-cadherin

Full Text

The Full Text of this article is available as a PDF (621.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bland K. I., Konstadoulakis M. M., Vezeridis M. P., Wanebo H. J. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg. 1995 Jun;221(6):706–720. doi: 10.1097/00000658-199506000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bongiorno P. F., al-Kasspooles M., Lee S. W., Rachwal W. J., Moore J. H., Whyte R. I., Orringer M. B., Beer D. G. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer. 1995 Jan;71(1):166–172. doi: 10.1038/bjc.1995.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996 Apr 4;380(6573):435–439. doi: 10.1038/380435a0. [DOI] [PubMed] [Google Scholar]
  4. Chambers A. F., Matrisian L. M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997 Sep 3;89(17):1260–1270. doi: 10.1093/jnci/89.17.1260. [DOI] [PubMed] [Google Scholar]
  5. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K. S., Powell-Braxton L., Hillan K. J., Moore M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996 Apr 4;380(6573):439–442. doi: 10.1038/380439a0. [DOI] [PubMed] [Google Scholar]
  6. Ferrara N. Vascular endothelial growth factor. Eur J Cancer. 1996 Dec;32A(14):2413–2422. doi: 10.1016/s0959-8049(96)00387-5. [DOI] [PubMed] [Google Scholar]
  7. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990 Jan 3;82(1):4–6. doi: 10.1093/jnci/82.1.4. [DOI] [PubMed] [Google Scholar]
  8. Gastl G., Hermann T., Steurer M., Zmija J., Gunsilius E., Unger C., Kraft A. Angiogenesis as a target for tumor treatment. Oncology. 1997 May-Jun;54(3):177–184. doi: 10.1159/000227685. [DOI] [PubMed] [Google Scholar]
  9. Ide H., Nakamura T., Hayashi K., Endo T., Kobayashi A., Eguchi R., Hanyu F. Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg. 1994 May-Jun;18(3):321–330. doi: 10.1007/BF00316810. [DOI] [PubMed] [Google Scholar]
  10. Jawhari A., Jordan S., Poole S., Browne P., Pignatelli M., Farthing M. J. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology. 1997 Jan;112(1):46–54. doi: 10.1016/s0016-5085(97)70218-x. [DOI] [PubMed] [Google Scholar]
  11. Kadowaki T., Shiozaki H., Inoue M., Tamura S., Oka H., Doki Y., Iihara K., Matsui S., Iwazawa T., Nagafuchi A. E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res. 1994 Jan 1;54(1):291–296. [PubMed] [Google Scholar]
  12. Kawahara E., Okada Y., Nakanishi I., Iwata K., Kojima S., Kumagai S., Yamamoto E. The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn J Cancer Res. 1993 Apr;84(4):409–418. doi: 10.1111/j.1349-7006.1993.tb00151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kurokawa Y. Experiments on lymph node metastasis by intralymphatic inoculation of rat ascites tumor cells, with special reference to lodgement, passage, and growth of tumor cells in lymph nodes. Gan. 1970 Oct;61(5):461–471. [PubMed] [Google Scholar]
  14. Lerut T., De Leyn P., Coosemans W., Van Raemdonck D., Scheys I., LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg. 1992 Nov;216(5):583–590. doi: 10.1097/00000658-199211000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Liotta L. A. Cancer cell invasion and metastasis. Sci Am. 1992 Feb;266(2):54-9, 62-3. doi: 10.1038/scientificamerican0292-54. [DOI] [PubMed] [Google Scholar]
  16. Liotta L. A., Stetler-Stevenson W. G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 1991 Sep 15;51(18 Suppl):5054s–5059s. [PubMed] [Google Scholar]
  17. Maeda K., Chung Y. S., Ogawa Y., Takatsuka S., Kang S. M., Ogawa M., Sawada T., Sowa M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996 Mar 1;77(5):858–863. doi: 10.1002/(sici)1097-0142(19960301)77:5<858::aid-cncr8>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  18. Moriyama M., Kumagai S., Kawashiri S., Kojima K., Kakihara K., Yamamoto E. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol. 1997 Sep;33(5):369–374. doi: 10.1016/s1368-8375(97)00025-0. [DOI] [PubMed] [Google Scholar]
  19. Nagashima M., Yoshino S., Ishiwata T., Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol. 1995 Sep;22(9):1624–1630. [PubMed] [Google Scholar]
  20. Nakanishi Y., Ochiai A., Akimoto S., Kato H., Watanabe H., Tachimori Y., Yamamoto S., Hirohashi S. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology. 1997 Mar-Apr;54(2):158–165. doi: 10.1159/000227681. [DOI] [PubMed] [Google Scholar]
  21. Ohta Y., Watanabe Y., Murakami S., Oda M., Hayashi Y., Nonomura A., Endo Y., Sasaki T. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br J Cancer. 1997;76(8):1041–1045. doi: 10.1038/bjc.1997.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Roberts W. G., Palade G. E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995 Jun;108(Pt 6):2369–2379. doi: 10.1242/jcs.108.6.2369. [DOI] [PubMed] [Google Scholar]
  23. Roder J. D., Busch R., Stein H. J., Fink U., Siewert J. R. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994 Mar;81(3):410–413. doi: 10.1002/bjs.1800810330. [DOI] [PubMed] [Google Scholar]
  24. Schipper J. H., Frixen U. H., Behrens J., Unger A., Jahnke K., Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991 Dec 1;51(23 Pt 1):6328–6337. [PubMed] [Google Scholar]
  25. Senger D. R., Van de Water L., Brown L. F., Nagy J. A., Yeo K. T., Yeo T. K., Berse B., Jackman R. W., Dvorak A. M., Dvorak H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993 Sep;12(3-4):303–324. doi: 10.1007/BF00665960. [DOI] [PubMed] [Google Scholar]
  26. Shigetomi A., Kotoh T., Harada T., Morikawa S., Nakamura T. [Development of an experimental model for spontaneous lymph node metastasis of human esophageal carcinoma in nude mice--histopathological analysis]. Hum Cell. 1992 Sep;5(3):273–281. [PubMed] [Google Scholar]
  27. Shima I., Sasaguri Y., Kusukawa J., Yamana H., Fujita H., Kakegawa T., Morimatsu M. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer. 1992 Dec 15;70(12):2747–2753. doi: 10.1002/1097-0142(19921215)70:12<2747::aid-cncr2820701204>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  28. Shimada Y., Imamura M., Shibagaki I., Tanaka H., Miyahara T., Kato M., Ishizaki K. Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. Ann Surg. 1997 Aug;226(2):162–168. doi: 10.1097/00000658-199708000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shimoyama Y., Hirohashi S., Hirano S., Noguchi M., Shimosato Y., Takeichi M., Abe O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 1989 Apr 15;49(8):2128–2133. [PubMed] [Google Scholar]
  30. Shiozaki H., Oka H., Inoue M., Tamura S., Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer. 1996 Apr 15;77(8 Suppl):1605–1613. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1605::AID-CNCR28>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  31. Tanigawa N., Matsumura M., Amaya H., Kitaoka A., Shimomatsuya T., Lu C., Muraoka R., Tanaka T. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer. 1997 Jan 15;79(2):220–225. [PubMed] [Google Scholar]
  32. Theunissen P. H., Borchard F., Poortvliet D. C. Histopathological evaluation of oesophageal carcinoma: the significance of venous invasion. Br J Surg. 1991 Aug;78(8):930–932. doi: 10.1002/bjs.1800780811. [DOI] [PubMed] [Google Scholar]
  33. Uchida S., Shimada Y., Watanabe G., Tanaka H., Shibagaki I., Miyahara T., Ishigami S., Imamura M. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer. 1998 May;77(10):1704–1709. doi: 10.1038/bjc.1998.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vogelstein B., Fearon E. R., Kern S. E., Hamilton S. R., Preisinger A. C., Nakamura Y., White R. Allelotype of colorectal carcinomas. Science. 1989 Apr 14;244(4901):207–211. doi: 10.1126/science.2565047. [DOI] [PubMed] [Google Scholar]
  35. Vojtesek B., Bártek J., Midgley C. A., Lane D. P. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods. 1992 Jul 6;151(1-2):237–244. doi: 10.1016/0022-1759(92)90122-a. [DOI] [PubMed] [Google Scholar]
  36. Wang D. Y., Xiang Y. Y., Tanaka M., Li X. R., Li J. L., Shen Q., Sugimura H., Kino I. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer. 1994 Dec 15;74(12):3089–3096. doi: 10.1002/1097-0142(19941215)74:12<3089::aid-cncr2820741205>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  37. Woodcock-Mitchell J., Eichner R., Nelson W. G., Sun T. T. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol. 1982 Nov;95(2 Pt 1):580–588. doi: 10.1083/jcb.95.2.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. von Wasielewski R., Rhein A., Werner M., Scheumann G. F., Dralle H., Pötter E., Brabant G., Georgii A. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Res. 1997 Jun 15;57(12):2501–2507. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES